Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression
- 9 January 2026
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 14 (3) , 387-398
Abstract
Pseudomonas aeruginosa infection is still a serious problem among immunocompromised patients who have advanced urinary tract malignancies, yet the impact of P. aeruginosa on disease progression remains poorly defined. In this study, we show that urinary tract infections caused by P. aeruginosa exacerbated bladder cancer progression in murine models, primarily by inducing an immunosuppressive tumor microenvironment. Mechanistically, P. aeruginosa activated Toll-like receptor 5 (TLR5) on bladder cancer cells, triggering phosphorylation of ERK1/2 and subsequent secretion of the chemokine CCL20. This signaling axis promoted the recruitment of myeloid-derived suppressor cells (MDSC), thereby reinforcing immunosuppression within the tumor microenvironment and exacerbating bladder cancer growth. In clinical samples, 16S rRNA sequencing and transcriptome analysis of bladder cancer tissues confirmed the presence of P. aeruginosa, with its abundance significantly correlating with advanced disease stages and elevated CCL20 expression. Collectively, these data identify a role for P. aeruginosa in promoting bladder cancer progression through TLR5–ERK1/2–CCL20–mediated MDSC recruitment, shedding light on the intricate interplay between microbial infection and cancer pathogenesis. These insights highlight potential therapeutic targets to disrupt infection-driven cancer progression.Keywords
All Related Versions
Funding Information
- National Key Research and Development Program of China (2022YFC2303000)
- National Natural Science Foundation of China (82371777)
- National Natural Science Foundation of China (82430072)
- National Natural Science Foundation of China (82101838)
This publication has 24 references indexed in Scilit:
- PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironmentGastric Cancer, 2023
- Implications of Toll-like receptors (TLRs) and their signaling mechanisms in human cancersPathology - Research and Practice, 2023
- Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon–degrading Bacteria Among Bladder Cancer PatientsEuropean Urology Oncology, 2023
- Toll-like Receptors and the Control of ImmunityCell, 2020
- CCL20 Signaling in the Tumor Microenvironment2020
- Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lungJournal of Cystic Fibrosis, 2019
- The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implicationsCancer Medicine, 2018
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentTrends in Immunology, 2016
- Clostridium difficile flagellin stimulates toll-like receptor 5, and toxin B promotes flagellin-induced chemokine production via TLR5Life Sciences, 2013
- Toll-like receptor 5- and lymphotoxin β receptor-dependent epithelial Ccl20 expression involves the same NF-κB binding site but distinct NF-κB pathways and dynamicsBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2009